Hints and tips:
...Judy Lewent, who served on the board of opioid drugmaker Purdue Pharma for more than four years until 2014, was named as a defendant in a lawsuit filed by the state’s attorney-general last month....
...Judy Lewent, who declined to comment via a GSK spokesperson, served on the board of opioid drugmaker Purdue Pharma for more than four years until 2014....
...She joins GSK with Judy Lewent, former finance director of Merck. Their appointments by GSK chairman Sir Chris Gent takes the female quotient of the 15-member board to three....
...Judy Lewent, chief financial officer, said Merck “continued to monitor” Vioxx legal defence needs and costs and evaluated necessary spending “every quarter”....
...Many Wall Street analysts have argued that Arcoxia might never win backing from the Food and Drug Administration, but Judy Lewent, the group’s chief financial officer, said its sales forecasts included “...
International Edition